Markis et al. have reported a higher frequency of B and T cells expressing GM-CSF in the peripheral blood of RA patients, suggesting that GM-CSF+ B cells probably contribute to autoantibody production and RA pathogenesis (26). The gene discussed is CSF2; the disease is rheumatoid arthritis.